SS&C Technologies Operating Cash Flow decreased by 53.4% to $299.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.1%, from $272.20M to $299.70M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 5.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $376.60M | $382.60M | $484.10M | $183.50M | $264.00M | $317.10M | $369.70M | $254.80M | $329.40M | $242.50M | $388.40M | $180.50M | $384.90M | $336.60M | $486.60M | $272.20M | $372.90M | $456.20M | $643.50M | $299.70M |
| QoQ Change | — | +1.6% | +26.5% | -62.1% | +43.9% | +20.1% | +16.6% | -31.1% | +29.3% | -26.4% | +60.2% | -53.5% | +113.2% | -12.5% | +44.6% | -44.1% | +37.0% | +22.3% | +41.1% | -53.4% |
| YoY Change | — | — | — | — | -29.9% | -17.1% | -23.6% | +38.9% | +24.8% | -23.5% | +5.1% | -29.2% | +16.8% | +38.8% | +25.3% | +50.8% | -3.1% | +35.5% | +32.2% | +10.1% |